Abnormal glucose tolerance and the risk of cancer death in the United States

scientific article

Abnormal glucose tolerance and the risk of cancer death in the United States is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/AJE/KWG100
P698PubMed publication ID12796045
P5875ResearchGate publication ID278917173

P50authorSharon SaydahQ90123741
Catherine M LoriaQ117242597
P2093author name stringFrederick L Brancati
Mark S Eberhardt
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectglycobiologyQ899224
glucoseQ37525
P304page(s)1092-1100
P577publication date2003-06-01
P1433published inAmerican Journal of EpidemiologyQ4744243
P1476titleAbnormal glucose tolerance and the risk of cancer death in the United States
P478volume157

Reverse relations

cites work (P2860)
Q37400511A cohort study of the risk of cancer associated with type 2 diabetes
Q34538052A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer
Q27331637Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment
Q39648521All-cause cancer mortality over 15 years in multi-ethnic Mauritius: the impact of diabetes and intermediate forms of glucose tolerance
Q51349843Association between glucose tolerance level and cancer death in a general Japanese population: the Hisayama Study.
Q57152332Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage study
Q37356443Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin
Q37155599Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma
Q34222524Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region
Q21090132Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts
Q54570063Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
Q35104958Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations
Q51370357Categories of glucose tolerance and continuous glycemic measures and mortality.
Q38684987Chemotherapy and Glycemic Control in Patients with Type 2 Diabetes and Cancer: A Comparative Case Analysis
Q37684154Consensus on the Prevention of Type 2 Diabetes in Chinese Adults
Q46171495Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study.
Q27657527Design of an Insulin Analog with Enhanced Receptor Binding Selectivity: RATIONALE, STRUCTURE, AND THERAPEUTIC IMPLICATIONS
Q47665989Diabetes and Overall Survival among Breast Cancer Patients in the U.S. Military Health System
Q38097984Diabetes and cancer relationships
Q36047297Diabetes and lung cancer among postmenopausal women
Q36637909Diabetes and risk of cancer
Q44370016Diabetes mellitus is associated with short prostate-specific antigen doubling time after radical prostatectomy
Q43057683Diabetes, prediabetes and cancer mortality
Q41842666Does metformin affect the incidence of colonic polyps and adenomas in patients with type 2 diabetes mellitus?
Q36677131Effects of cancer comorbidity on disease management: making the case for diabetes education (a report from the SOAR program).
Q34520129Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare.
Q51501226Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria.
Q51343811Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study.
Q54649308Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus.
Q44737786Gestational diabetes and risk of incident primary cancer: a large historical cohort study in Israel
Q37364601Glucocorticoid-induced hyperglycemia is prevalent and unpredictable for patients undergoing cancer therapy: an observational cohort study
Q44962985Glycemic index and colorectal carcinogenesis
Q43541452Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease
Q37375845HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women
Q37199364High prevalence of diabetes mellitus and impaired glucose tolerance in liver cancer patients: A hospital based study of 4610 patients with benign tumors or specific cancers
Q34076153Hyperglycemia, impaired glucose tolerance and elevated glycated hemoglobin levels in a long-lived mouse stock
Q30912182Impaired glucose metabolism among those with and without diagnosed diabetes and mortality: a cohort study using Health Survey for England data
Q59265277Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer
Q34925766Increased risk of colon cancer in men in the pre-diabetes phase
Q35554181Inhibitory effect of metformin therapy on the incidence of colorectal advanced adenomas in patients with diabetes
Q55385002Insulin glargine affects the expression of Igf-1r, Insr, and Igf-1 genes in colon and liver of diabetic rats.
Q35578858Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers
Q34989798Levels of certain tumor markers as differential factors between bilharzial and non-biharzial bladder cancer among Egyptian patients
Q34976375Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis
Q37554697Metformin effects revisited
Q34424886Metformin for aging and cancer prevention
Q35828675Metformin potentiates rapamycin and cisplatin in gastric cancer in mice
Q36524748Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning
Q61805534Mortality risk in adults according to categories of impaired glucose metabolism after 18 years of follow-up in the North of Spain: The Asturias Study
Q35137438On the status and comparison of glucose intolerance in female breast cancer patients at initial diagnosis and during chemotherapy through an oral glucose tolerance test.
Q37630970Plasma glucose regulation and mortality in Korea: a pooled analysis of three community-based cohort studies
Q36769486Pre-diagnosis blood glucose and prognosis in women with breast cancer.
Q33879153Pre-existing type 2 diabetes and risk of lung cancer: a report from two prospective cohort studies of 133 024 Chinese adults in urban Shanghai
Q35246551Prediabetes and the risk of cancer: a meta-analysis.
Q37094633Proteinuria as a risk factor for mortality in patients with colorectal cancer
Q53628117Relationship between HbA(1)c and mortality in a Japanese population.
Q37483954Relationship between level of HbA1C and breast cancer
Q36461174Relationship between metabolic syndrome and thyroid nodules in healthy Koreans
Q40131499Response to Intravenous Glucose-Tolerance Test and Risk of Cancer: A Long-Term Prospective Cohort Study
Q34234264Risk of cancer in a large cohort of U.S. veterans with diabetes.
Q35059999Serum glucose and risk of cancer: a meta-analysis
Q33585663Significantly increased risk of cancer in diabetes mellitus patients: A meta-analysis of epidemiological evidence in Asians and non-Asians
Q34153922Survival of Women with Colon Cancer in Relation to Precancer Anthropometric Characteristics: the Iowa Women's Health Study
Q33893799The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer
Q26991486The metabolic and mitogenic properties of basal insulin analogues
Q36303910Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer
Q33795313Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
Q37651046Undiagnosed diabetes in breast, colorectal, lung, and prostate cancer: incidence and risk factors.

Search more.